首页|期刊导航|Health Care Science|Electroacupuncture for Managing Chemotherapy-Induced Gastrointestinal Symptom Clusters in Patients With Breast Cancer:Study Protocol for a Randomized Controlled Trial

Electroacupuncture for Managing Chemotherapy-Induced Gastrointestinal Symptom Clusters in Patients With Breast Cancer:Study Protocol for a Randomized Controlled TrialOA

中文摘要

Introduction:Chemotherapy-induced gastrointestinal symptom clusters in breast cancer impair quality of life and treatment adherence,yet lack effective interventions.While acupuncture mitigates isolated chemotherapy-induced symptoms,its mechanisms for multi-symptom clusters remain unclear.This study evaluates electroacupuncture''s efficacy and explores its biological mechanisms in managing these clusters.Methods:This prospective,multicenter,block-randomized,double-blind,sham-controlled trial will enroll 388 patients with breast cancer undergoing neoadjuvant/adjuvant chemotherapy,to be randomly assigned(1:1)to electroacupuncture or sham electro-acupuncture groups.Both groups will receive the standard quadruple antiemetic regimen combined with electroacupuncture or sham intervention.The primary endpoint is the incidence of chemotherapy-induced gastrointestinal symptom clusters within 120 h after chemotherapy.Secondary endpoints include improvement in gastrointestinal symptom clusters post-first chemotherapy cycle,nausea-free rates during acute and delayed phases,vomiting-free rates during overall,acute,and delayed phases,complete response rate,complete protection rate,and quality of life.Adverse events will be documented throughout the study.Discussion:This study will assess the efficacy and safety of electroacupuncture in alleviating chemotherapy-induced gastro-intestinal symptom clusters in patients with breast cancer.By integrating multi-omics analyses,we aim to elucidate the biological mechanisms underlying its therapeutic effects.The findings may offer a robust clinical foundation for optimizing symptom cluster management in cancer care.Trial Registration:Clinical Trials ID:NCT06952920.Date of registration:April 16,2025.Prospectively registered.URL of Trial Registry Record:https://clinicaltrials.gov/study/NCT06952920cond=NCT06952920&rank=1.

Xinlong Tao;Zhen Liu;Miaozhou Wang;Dengfeng Ren;Fuxing Zhao;Hongbin Wang;Guowang Yang;Ganlin Zhang;Zitao Li;Zhilin Liu;Shifen Huang;Yongzhi Chen;Mengting Da;Xiaoyan Ma;Hongxia Liang;Yongxin Li;Yinyin Ye;Yonghui Zheng;Xiao Liang;Guoshuang Shen;Xiaorong Bai;Jiuda Zhao

Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaDepartment of Traditional Chinese Medicine,Affiliated Hospital of Qinghai University,Xining,ChinaBeijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University,Beijing,ChinaBeijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University,Beijing,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,ChinaSun Yat-sen University Cancer Center Gansu Hospital,Lanzhou,ChinaBreast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University&Affiliated Cancer Hospital of Qinghai University,Xining,China

医药卫生

breast cancerchemotherapy-induced gastrointestinal symptom clusterselectroacupuncturestandard quadruple antiemetic therapy

《Health Care Science》 2026 (1)

P.85-94,10

Noncommunicable Chronic Diseases-National Science and Technology Major Project,Grant/Award Numbers:2024ZD0521400,2024ZD0521404Affiliated Hospital of Qinghai University。

10.1002/hcs2.70056

评论